| Amgen's Aranesp Increases Stroke Risk in Diabetic CKD Patients - Renal Business Today |
|
|
Renal Business Today"As the first, large-scale placebo-controlled study to examine the use of anemia therapy in diabetic CKD patients not on dialysis, the TREAT results ... read more |